Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report

Saya Takebe, Yasufumi Seki, Satoshi Morimoto, Daisuke Watanabe, Atsuhiro Ichihara

Open source

DOI
10.1016/j.aed.2026.04.008
Published
2026-07
Container
AACE Endocrinology and Diabetes
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.aed.2026.04.008,
  title = {Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report},
  author = {Saya Takebe and Yasufumi Seki and Satoshi Morimoto and Daisuke Watanabe and Atsuhiro Ichihara},
  year = {2026},
  journal = {AACE Endocrinology and Diabetes},
  doi = {10.1016/j.aed.2026.04.008},
  url = {https://doi.org/10.1016/j.aed.2026.04.008}
}

RIS

TY  - JOUR
TI  - Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report
AU  - Saya Takebe
AU  - Yasufumi Seki
AU  - Satoshi Morimoto
AU  - Daisuke Watanabe
AU  - Atsuhiro Ichihara
PY  - 2026
JO  - AACE Endocrinology and Diabetes
DO  - 10.1016/j.aed.2026.04.008
UR  - https://doi.org/10.1016/j.aed.2026.04.008
ER  - 

APA

Takebe, S., Seki, Y., Morimoto, S., Watanabe, D., & Ichihara, A. (2026). Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.04.008

Source records